BBC News regarding NICE appraisal of dasatinib and nilotinib
http://news.bbc.co.uk/1/hi/england/london/8440877.stm
JOURNAL OF CLINICAL ONCOLOGY
EDITORIAL
Chronic Myeloid Leukemia: Reversing the Chronic Phase
John M. Goldman, Imperial College London, London, United Kingdom
Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia
J Clin Oncol. 2009 Dec 14; Epub online ahead of print, JE Cortes , D Jones, S O'Brien, E Jabbour, F Ravandi, C Koller, G Borthakur, B Walker, W Zhao, J Shan, H Kantarjian
From Gleevec to Tasigna: Novartis' Switch Push Kicks Off With Front-Line CML Submission
The Pink Sheet Daily. 2009 Dec 9, J Merrill
Interactive
ecancer blog
Crucial differences between cancer and normal stem cells
18/12/2009
Posted by Dr. Clare Sansom, freelance
This is a compilation of the best/most relevant abstract presented at ASH conference this year. It was written by my friend and CML colleague, Jan Geissler, Director of leukemie-online.de
American Society of Heamatology Conference, New Orleans, Dec. 2009.
Scanned copy of the article featuring Jed and Bhiru Alexander in the Daily Mail
News of the World:
www.newsoftheworld.co.uk/news/610179/Health-service-PAYS-to-block-life-saving-drugs-for-desperate-patients
Please find a template letter written by Jed and freely shared by him with you. I suggest that you try to include your own viewpoint about the situation.